Breast Cancer Biomarkers: Challenges in Routine Estrogen Receptor, Progesterone Receptor, and HER2/neu Evaluation.

CONCLUSIONS.—: Attention must be given to specimen handling to ensure accurate ER, PR, and HER2 biomarker assessment and appropriate management of breast cancer patients. PMID: 31373514 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31373514?dopt=Abstract

Source: Archives of Pathology and Laboratory Medicine - August 1, 2019 Category: Laboratory Medicine Authors: Jorns JM Tags: Arch Pathol Lab Med Source Type: research